+15,818.7%
TT vs GSK
+1,705.8%
+14,112.8%
-77.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1990-01-01 to 2026-09-04.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | -1.9% | +2.8% | +1.5% |
| 7D | 0.0% | -1.8% | +1.8% | +0.6% |
| 30D | -7.2% | -2.2% | -5.0% | -6.6% |
| 3M | -3.0% | -1.8% | -1.2% | -2.9% |
| 6M | +1.4% | -10.6% | +12.0% | +4.8% |
| YTD | +15.9% | +4.4% | +11.5% | +13.0% |
| 1Y | +9.4% | +30.4% | -21.0% | -1.9% |
| 3Y | +124.4% | +60.1% | +64.3% | +81.4% |
| 5Y | +138.0% | +46.8% | +91.2% | +95.8% |
| 10Y | +886.4% | +79.2% | +807.2% | +640.4% |
| All | +15,818.7% | +1,705.8% | +14,112.8% | +5,725.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1990-01-01 to 2026-09-04: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1990-01-01 to 2026-09-04 analysis · Full analysis span regression · 6 months rolling